Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Theoharis C. Theoharides
Based on 7 articles published since 2008
||||
Expertise Level
The expertise of Theoharis C. Theoharides ranks in the
  • Top 6.4%
  • ... of 38,074 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Theoharides, Theoharis C   ·   Theoharides, T C
Work Locations
Details
Most likely:    Tufts University      
2018
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA. · Graduate Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, USA. · Department of Internal Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA. · Pubmed 29105195
2017
  • 1 Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA. · 2 Sackler School of Graduate Biomedical Sciences and Tufts University School of Medicine, Boston, MA, USA. · 3 Department of Internal Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA. · Pubmed 28480804
2014
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America. · Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Biochemistry, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America. · First Department of Dermatology, A. Sygros Hospital, Athens University Medical School, Athens, Greece. · Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America ; Graduate Program in Biochemistry, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America ; Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, United States of America. · Pubmed 24587411
2010
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and Maternal-Fetal Medicine, Tufts Medical Center, Boston, MA 02111, USA. · Pubmed 20160089
2012
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA. · Pubmed 22283733
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Theoharis C. Theoharides in 2008-2019 about Psoriasis:

  • TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. 2018
  • Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion. 2017
  • Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin. 2014
  • Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells. 2012
  • Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis. 2012
  • IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. 2010
  • IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. 2010
Show List of Full Article Records
Google Searches

Learn more about Theoharis C. Theoharides using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Tufts University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Tufts University
2018
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA. · Graduate Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, USA. · Department of Internal Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA. · Pubmed 29105195
2017
  • 1 Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA. · 2 Sackler School of Graduate Biomedical Sciences and Tufts University School of Medicine, Boston, MA, USA. · 3 Department of Internal Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA. · Pubmed 28480804
2014
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America. · Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Biochemistry, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America. · First Department of Dermatology, A. Sygros Hospital, Athens University Medical School, Athens, Greece. · Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Graduate Program in Pharmacology and Experimental Therapeutics, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America ; Graduate Program in Biochemistry, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America ; Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts, United States of America. · Pubmed 24587411
2010
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, and Maternal-Fetal Medicine, Tufts Medical Center, Boston, MA 02111, USA. · Pubmed 20160089
2012
  • Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA. · Pubmed 22283733
Yearly article counts 011001020200
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.